Virax Biolabs Group (VRAX) News
NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VRAX news summary
We found 1 recent headline mentioning Virax Biolabs Group (VRAX): 0 in the past week and 1 in the past 30 days, most often from PR Newswire. VRAX is making an outsized move today, down 12.89% at $0.3319, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China", was published by PR Newswire on Oct 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology